Literature DB >> 8156439

Vesicular transport of peroxidase in human eosinophilic myelocytes.

A M Dvorak1, P Estrella, T Ishizaka.   

Abstract

We performed ultrastructural cytochemistry to detect peroxidase in developmentally arrested human eosinophilic myelocytes. Human umbilical cord blood mononuclear cells were cultured for 21 days in the presence of murine-derived conditioned media, resulting in the development of eosinophilic myelocytes. Unlike normally developing eosinophilic myelocytes, which contain peroxidase in synthetic organelles (i.e. cisterns surrounding the nucleus and bounded by the rough endoplasmic reticulum and Golgi structures) and in immature and mature granules, the developmentally arrested cells showed ultrastructural evidence of decreased synthesis and secretory transport of peroxidase. Thus, peroxidase was generally absent in the perinuclear and rough endoplasmic cisterns, in Golgi structures, in immature granules and in the matrix compartment of most mature granules. Rather, biocompartmental specific granules displayed empty, peroxidase-negative matrix and central, peroxidase-negative core material. Peroxidase was present in perigranular vesicles, some of which were attached to granules. Such peroxidase-loaded transport vesicles are similar to those that effect piecemeal degranulation of mature human eosinophils cultured in rhIL-5-containing media [1]. These findings establish vesicle-mediated piecemeal degranulation in the secretory repertoire of immature human eosinophils and suggest the possibility that eosinophilic myelocytes may participate in vivo in important physiological and/or pathological events that require selective secretion from the specific granule matrix compartment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156439     DOI: 10.1111/j.1365-2222.1994.tb00910.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

1.  A gel-based dual antibody capture and detection method for assaying of extracellular cytokine secretion: EliCell.

Authors:  Lisa A Spencer; Rossana C N Melo; Sandra A C Perez; Peter F Weller
Journal:  Methods Mol Biol       Date:  2005

Review 2.  Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.

Authors:  Rossana C N Melo; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

Review 3.  Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Histol Histopathol       Date:  2010-10       Impact factor: 2.303

4.  Interleukin-13 in Asthma and Other Eosinophilic Disorders.

Authors:  Emma Doran; Fang Cai; Cécile T J Holweg; Kit Wong; Jochen Brumm; Joseph R Arron
Journal:  Front Med (Lausanne)       Date:  2017-09-19

Review 5.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

6.  Morphology and cytochemical patterns of peripheral blood cells of tiger frog (Rana rugulosa).

Authors:  Xianxian Chen; Yu Wu; Lixin Huang; Xue Cao; Misbah Hanif; Fei Peng; Xiaobing Wu; Shengzhou Zhang
Journal:  PeerJ       Date:  2022-08-29       Impact factor: 3.061

7.  Epithelial Autoantigen-Specific IgG Antibody Enhances Eosinophil Extracellular Trap Formation in Severe Asthma.

Authors:  Youngwoo Choi; Hae-Sim Park; Dong-Hyun Lee; Jae-Hyuk Jang; Soyoon Sim
Journal:  Allergy Asthma Immunol Res       Date:  2022-09       Impact factor: 5.096

8.  Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Josiane S Neves; Staci P Bafford; Ellen S Morgan; Ann M Dvorak; Peter F Weller
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

Review 9.  Eosinophils: changing perspectives in health and disease.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

Review 10.  Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far.

Authors:  Senbagavalli Prakash Babu; Prakash B Narasimhan; Subash Babu
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.